MorphoSys AG (MOR) Thursday said it has entered into a delisting agreement with Novartis BidCo AG and Novartis AG upon closing the acquisition by Novartis in May this year.
In April, Novartis had submitted a voluntary public takeover offer for all outstanding shares of MorphoSys with an offer price of 68 euros per share, in cash. The acceptance period of the takeover offer and the statutory two-week additional acceptance period ended on May 13, and May 30 respectively.
As of June 20, Novartis holds about 91.04% stake in MorphoSys, making MorphoSys a Novartis company.
Novartis plans to merge MorphoSys by implementing a squeeze-out of MorphoSys' minority shareholders.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.